Stockreport

argenx Reports Half Year 2025 Financial Results and Provides Second Quarter Business Update

argenx SE - American Depositary Shares  (ARGX) 
PDF $949 million in second quarter global product net sales VYVGART SC launch in CIDP progresses with more than 2,500 patients on treatment globally ARGX-119 to advance [Read more]